eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hepatitis c |
| Comorbidity | |liver disease |
| Sentences | 76 |
| PubMedID- 20713178 | Prevalence and challenges of liver diseases in patients with chronic hepatitis c virus infection. |
| PubMedID- 24815847 | Chronic liver disease due to hepatitis c affects a large number of hiv-infected patients in latin america and currently poses important challenges for the health systems in the region. |
| PubMedID- 23703797 | Vitamin d is an important immune modulator that plays an emerging role in inflammatory and metabolic liver diseases, including infection with hepatitis c virus (hcv). |
| PubMedID- 21209701 | End-stage liver disease due to hepatitis c (hcv) and cirrhosis from alcohol (ald) are the commonest indications for liver transplantation in the western countries. |
| PubMedID- 20386865 | The mechanisms by which alcohol consumption accelerates liver disease in patients with chronic hepatitis c virus (hcv) are not well understood. |
| PubMedID- 25320839 | Background: heavy alcohol use has been hypothesized to accelerate disease progression to end-stage liver disease in patients with hepatitis c virus (hcv) infection. |
| PubMedID- 24224747 | We analysed data from 275 chronic hepatitis c (chc) patients with compensated liver disease who underwent 318 courses of pegifna and ribavirin. |
| PubMedID- 26503379 | Moderate sustained virologic response rates with 6-week combination directly acting anti-hepatitis c virus therapy in patients with advanced liver disease. |
| PubMedID- 20424599 | For hb, achieving safe, effective gene transfer in skeletal muscle would afford a therapeutic alternative to those patients with advanced liver disease due to hepatitis c contracted from plasma-derived coagulation concentrates. |
| PubMedID- 20517909 | Timing of hepatitis c antiviral therapy in patients with advanced liver disease: a decision analysis model. |
| PubMedID- 23630437 | Status of essential trace minerals and oxidative stress in viral hepatitis c patients with nonalcoholic fatty liver disease. |
| PubMedID- 21809486 | The purpose of this study was to determine the serum level of oxidized low-density lipoprotein (ox-ldl), and evaluate its association with different clinically valuable parameters of liver disease in patients with chronic hepatitis c. |
| PubMedID- 25030555 | Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis c. |
| PubMedID- 21326625 | The patient's past medical history was significant for end-stage liver disease due to hepatitis c and hepatitis b, asthma, and erythropoietic porphyria. |
| PubMedID- 21057160 | Twenty-one patients (62%) had liver disease associated with hepatitis c virus (hcv) and 5 patients with hepatitis b virus (62%). |
| PubMedID- 23213601 | 46-year-old female patient whose blood group was “a1 positive” underwent deceased donor liver transplantation (ddlt) from identical blood group donor for end-stage liver disease due to hepatitis c with meld score of 26. pre-operatively, she had comorbidities in the form of diabetes mellitus and recurrent hepatic hydrothorax requiring frequent therapeutic aspiration. |
| PubMedID- 21957404 | Fifteen patients suffered from end-stage liver disease due to hepatitis c; 7, due to hepatitis c with hepatocellular carcinoma; and the remaining 3, due to hepatocellular carcinoma with negative viral markers. |
| PubMedID- 25457210 | Background & aims: genetic variants of patatin-like phospholipase domain-containing 3 (pnpla3) and diabetes are associated with liver disease severity, in patients with chronic hepatitis c (chc) infection. |
| PubMedID- 22172892 | A 43-year-old man with end-stage liver disease due to hepatitis c and b virus infections and alcoholic cirrhosis received a liver transplantation under immunosuppressive treatment with tacrolimus and mycophenolate mofetil. |
| PubMedID- 21645344 | In this article we discuss several liver conditions which are directly affected by overweight and obese status, including non-alcoholic fatty liver disease, chronic infection with hepatitis c virus and post-liver transplant status. |
| PubMedID- 23241078 | The economic burden of advanced liver disease among patients with hepatitis c virus: a large state medicaid perspective. |
| PubMedID- 26125137 | Low cross-neutralization of hepatitis c correlates with liver disease in immunocompromized patients. |
| PubMedID- 22721429 | An infection of hepatitis c virus may lead to serious liver diseases including chronic hepatitis, cirrhosis and hepatocellular carcinoma with poor prognosis [1-4]. |
| PubMedID- 20367803 | liver disease due to hepatitis c virus (hcv) infection is a leading cause of non-aids-related morbidity and mortality in patients infected with hiv. |
| PubMedID- 24723944 | Had underling liver disease with mostly hepatitis c virus (hcv) serologically positive (123/271, 45.4%) but not with hbv (78/271, 28.8%); however, the patients in our study were most hbv serologically positive (312/413, 75.5%). |
| PubMedID- 22098185 | Evaluation of the adverse effect of premature discontinuation of pegylated interferon alpha-2b and ribavirin treatment for chronic hepatitis c virus infection: results from kyushu university liver disease study. |
Page: 1 2